Up a level |
Number of items: 1.
Heist, R. S., Garon, E. B., Groen, H. J. M., Tan, D. S. W., Tanriverdi, O., Robeva, A., Le Mouhaer, S., Carbini, M., Agostinho, A. Chassot and Wolf, J. (2021). Capmatinib safety update in MET dysregulated NSCLC from the GEOMETRY mono-1 trial. Ann. Oncol., 32. S. S986 - 2. AMSTERDAM: ELSEVIER. ISSN 1569-8041